Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Upcoming Life Science Webinars

  Date Webinar Title Synopsis

Oct 19, 2017 Cardiovascular Imaging for Monitoring Safety: Visualizing Outcomes

LifeScience - The goal of this webinar is to discuss the application of cardiovascular imaging when monitoring safety in the development of new medical therapies
Speakers:
Tim Crowe, Director, Cardiovascular Imaging Services, Bioclinica
Bruce Lloyd, MD, Associate Medical Director and Director of Clinical Cardiology Services, Bioclinica
Blaine Horvath, Medical Affairs Advisor, Bioclinica

Oct 19, 2017 Treatment Allocation in Randomized Trials: Challenges and Best Practices LifeScience - This webinar will discuss the rationale for the various randomization methods, with illustration from real clinical trials and some considerations about the performance characteristics of the different methods
Speakers:Everardo Saad, MD, Medical Director, International Drug Development Institute (IDDI)
Linda Danielson, MS, Chief Operating Officer, Executive VP, International Drug Development Institute (IDDI)

Oct 23, 2017 Brexit – Separating Fact from Fiction LifeScience -  PCI Clinical Services and its Guests discuss Brexit and its impact on Clinical Trials in the EU and UK
Speakers: Dr. Fiona Withey, Managing Director, UK Clinical Services, PCI
Tristram Evans, Quality Director, PCI Clinical Services
Dr. Peter Clarke, SVP CMC, PsiOxus
Tony Street, Global Head of Solutions Consulting - PAREXEL Clinical Trial Supplies and Logistics
Ian Price, Director, CBI Wales

Oct 24, 2017 Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond LifeScience - Join the speakers to learn good publication practices that will help to streamline your interactions with scientific authors, while enhancing the quality, efficiency and effectiveness of industry-sponsored research projects
Speakers:
Surendra Sharma, MD, Medical Communications Leader, Spark Therapeutics
Janet Galliera, Executive Director Business Development, PubsHub, an ICON plc company

Oct 24, 2017 Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms

LifeScience - In this webinar the presenters will give an overview of their large scale WGS library and sequencing pipelines, and improvements made for sequencing on HiSeq X platform and share their experiences on the NovaSeq platform
Speakers:
Robert Fulton, M.S., Director of Development, McDonnell Genome Institute, Washington University
HarshaVardhan Doddapaneni, Ph.D., Assistant Professor, Human Genome Sequencing Center, Baylor College of Medicine

Oct 26, 2017 Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution

LifeScience - This presentation will highlight the role electronic expert evaluation plays in improving the quality of endpoint assessments for cardiovascular outcomes. A detailed discussion on the Clinical Event adjudication process workflow will be shared
Speakers:
Lisa Chwieroth, Director of Clinical Event Committee (CEC) Operations, Bioclinica
Souhil Zaim MD, Head of Global Medical and Science Affairs, Bioclinica
Stephen D. Wiviott, MD, FACC, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School

Oct 26, 2017 Pharmacovigilance Database E2B(R3) Compliance: A Technical and Practical Perspective LifeScience - This webinar is suitable for both those looking for an introduction to the updated pharmacovigilance standards and those looking to ensure they can implement the necessary changes within their department or team
Speakers: Tom Nichols, Senior Director, Pharmacovigilance, Quanticate
Dr. Marc Zittartz, Chief Quality Officer, pharmasol

Oct 27, 2017 Simplify Your Research with A New Generation of High Resolution QTof Mass Spectrometer LifeScience - Current QTOF analyzers that provide resolution >30,000 and mass-to-charge error <5ppm, are generally well suited for HRAM in many aspects, including providing high quality data with no degradation in resolving power or accuracy, making it an excellent match for high resolution separation technologies
Speaker: Robert E. Haufler, Ph.D., Staff Scientist, SCIEX

Oct 30, 2017 Applying ICH GCP E6(R2) Guidelines to All Aspects of Clinical Trials LifeScience -  Key topics for this webinar include how Sponsors can conduct independent verification of the quality and integrity of the data collected from sites, minimize risk for patients, optimize costs through more efficient monitoring, detect trial misconduct, and meet regulatory requirements and follow guidelines related to taking a risk-based approach and interrogation of data 
Speaker: Rob Nichols, Chief Commercial Officer, Director, Algorics
Giulia Zardi, Biostatistician, CROS NT

Oct 30, 2017 Efficiently Managing Your Drug Supply Beyond IRT LifeScience - Learn about the benefits of using a supply management tool that enables global inventory management across a sponsor’s entire portfolio starting from brite stock through destruction
Speaker: Brett Castano, Senior Architect, Project Management, endpoint Clinical

Oct 31, 2017 How Leveraging an Asia-Pacific Network Can Create Regional Efficiencies in Clinical Supply Management LifeScience - In this webinar, our featured speaker will explore how to leverage the major clinical supply centers of China, Singapore and Japan to support clinical trials within the Asia-Pacific region for both local and global study sponsors
Speaker: Daniel Gao, Site Director, Clinical Supply Services – Shanghai, Catalent

Nov 1, 2017 Key Takeaways from the New CSRC/FDA Meeting on Cardiac Safety and Cardiovascular Safety Issues in Oncology Drug Development LifeScience - In this webinar learn about the updates from the new CSRC/FDA meeting on cardiac safety and cardiovascular safety issues in oncology drug development to optimize your clinical trial.
Speakers: Polina Voloshko, MD, Chief Medical Officer, BioTelemetry Research
Daniel Goodman, MD, VP, Medical Director, BioTelemetry Research

 

Nov 1, 2017 Infectious Diseases in the Immunocompromised Host – A Dynamic Landscape with Challenges for Clinical Development LifeScience - This webinar will discuss infectious diseases in the immunocompromised host—with a focus on hematologic malignancies and hematopoietic cell transplantation patients—and the unique challenges for clinical development
Speakers: Hervé Momméja-Marin, MD, Senior Medical Director, Infectious Diseases & Vaccines, Medpace
Anibal Calmaggi, MD, Senior Medical Director, Infectious Diseases & Vaccines, Medpace
Gregory Hale, MD, Senior Medical Director, Hematology & Oncology, Medpace

Nov 2, 2017 The Journey from Passive to Active TMF with C.R. Bard, Inc. and Daiichi Sankyo LifeScience - As the industry continues its move from passive to active model, this webinar features two organizations who are currently on the journey to optimize their TMFs
Speakers: Julia Lombardo, EClinical Applications Manager, C.R. Bard
Jamie Toth, Director and Head of TMF Operations, Daiichi Sankyo
Jason Methia, VP, Vault Clinical, Enterprise, Veeva

Nov 3, 2017 Building Smart Biomedical Devices Using Glass, Lasers, Sensors, and Chips

LifeScience -  This webinar will explain where Glass Core Technology will lead out customers to new products with a higher level of integration and more innovative features that result in smart biomedical devices and other emerging technologies
Speaker: Steve Groothuis, Chief Technology Officer, Samtec Microelectronics

Nov 3, 2017 Simple and Cost-Effective Ways to Engage Patients Using eCOA and IRT Systems LifeScience - A case study will highlight effective use of an IRT system to support patient communications during a clinical trial involving chronic obstructive pulmonary disease
Speakers: Carrie Lewis, MS, Associate Director, Clinical Operations, Lupin Research Inc.
Bryan Clayton, Vice President, Strategic Solutions, YPrime

Nov 6, 2017 Drug Name Development: The Regulatory Changes to Know About & How to Prepare for a Successful 2018 LifeScience - This webinar will discusss securing drug name approvals from three major regulatory bodies: FDA, EMA and Health Canada
Speakers from Addison Whitney:
Brittany Scott, Creative Director; Betsy Lard, VP, Managing Director; Barbara Gerber, VP, Managing Director – London; Nancy Kirschbaum, Senior Director, Regulatory Strategy and Consulting

Nov 7, 2017 Preparing for Phase II: Finding the Right Dose, Schedule, and Combination from your Phase I/II Oncology Clinical Trial LifeScience - This webinar will review these and other factors important to planning and executing early-phase oncology clinical trials in preparation for a decision-making Phase II trial
Speakers: Paul Hallenbeck, Ph.D., Executive Director, Strategic Development, Oncology, Premier Research
Peter Larson, M.D., Senior Medical Director, Hematology-Oncology, Premier Research
Gabriele Accetta, Principal Biostatistician, Premier Research


Nov 8, 2017 Delivering Efficiencies via the Functional Service Provider Model for Investigator Payments LifeScience - The speakers will discuss some of the best practices and crucial elements for executing successful FSP engagements specifically for site payments
Speakers: Victoria Moore, FCCA Executive Director Global Business Finance, INC Research/inVentiv Health
Shaun Williams, Senior Director, Investigator Payments, INC Research/inVentiv Health


Nov 9, 2017 First-In-Human Studies – An Examination of the Evolving Regulatory and Clinical Practices LifeScience - In this webinar, INC Research/inVentiv Health experts will discuss the evolving regulatory and clinical requirements to ensure safety and compliance when conducting First-in-Human studies
Speakers: John Oldenhof, PhD, Executive Director, Clinical Pharmacology, Early Phase, INC Research/inVentiv Health
Richard Larouche, VP Medical Affairs, Early Stage Clinical Operations, INC Research/inVentiv Health
Clark Williard, Executive Director, Bioanalysis, Early Stage Bioanalytical Labs, INC Research/inVentiv Health


Nov 10, 2017 Reinvigorating Kidney Disease R&D: Latest Innovations Aim to Address Vast Unmet Need LifeScience - This webinar will examine new and more advanced and personalized precision medicine approaches to kidney disease research, including both potential drugs and technologies
Speaker: Eric B. Grossman, MD, Vice President and Medical Director, Clinipace Worldwide

Nov 13, 2017 Conducting Early Phase Oncology Studies - Successfully Moving Through to Proof of Concept and Beyond LifeScience - This webinar will focus on considerations for small, young biotech when selecting a clinical research organisation (CRO) to take their molecule through to proof of concept and beyond
Speakers: Shankar Balaratnam, MBBS, MSc, MRCS, MFPM, Associate Medical Director, Simbec-Orion Group
Claire Barton, MA, MB, BChir, MRCP, PhD, FFPM, Orion Clinical Oncology Advisory Board Member

Nov 14, 2017 A Vast Unmet Need: Challenges in Alzheimer’s Clinical Trials LifeScience - This webinar will review the current global pipeline of Alzheimer’s trials and their geographic locations, describe innovations in trial design, and promote consideration of optimal clinical trial processes, including preclinical patient populations, clinical assessments sensitive to the earliest disease-related changes, and biomarkers as outcomes of clinical trials
Speakers: Krista Armstrong, Vice President & Head of Neuroscience, Premier Research
Sebastian Turek, Project Director, Premier Research

Nov 14, 2017 Best Practices in Clinical Pharmacology Gap Analysis LifeScience - Viewers will learn how gap analysis can help ensure that development programs will contain all the elements needed to satisfy regulators and investors during all phases of drug development from Investigational New Drug (IND) to NDA
Speaker: Julie Bullock, Senior Director of Consulting Services, Certara

 

Nov 15, 2017 Rare Disease Disorders and CNS Drug Development – Paving the Way for Precision Medicine LifeScience - Topics include the shifting clinical development landscape, the history of treatment of rare diseases with CNS manifestations, operational lessons-learned in identifying, enrolling and retaining rare disease populations in clinical trials, and new approaches to deliver disease specific targeted therapies to the CNS
Speakers: James Vornov, MD, PhD, Vice President of Medical Affairs, Neurology, Medpace
Richard Scheyer, MD, Vice President of Medical Affairs, Neurology, Pharmacology, Medpace
Terence Eagleton, MBBS, BSc, Senior Medical Director, Rare Diseases, Medpace
Michelle Petersen, MS, Sr. Associate Director, Clinical Trial Management, Medpace

Nov 16, 2017 New Tufts Research: EDC Trends, Insights, and Opportunities LifeScience - Hear new research from Tufts Center for the Study of Drug Development on current and evolving EDC practices across the drug development enterprise
Speakers: Ken Getz, MBA, Director of Sponsored Research Programs & Research Associate Professor, Tufts Center for the Study of Drug Development
Richard Young, Vice President, Veeva Vault EDC, Veeva Systems

Nov 21, 2017 Multiplex IHC Immuno-Oncology Panel LifeScience - This webinar will discuss standardized profiling of the immune status based on spatial and functional characterization of the tumor microenvironment
Speaker: Dr. Svenja Lippok, Product Marketing Manager, Definiens AG

Nov 28, 2017 Removing Risk from Clinical Trial Management System (CTMS) Implementations

LifeScience - This webinar will demonstrate how organizations can mitigate many of the common risks and challenges of implementing CTMS systems by starting with a small, limited implementation
Speaker:
Justin Hunt, Director, CTMS Implementation Services, Bioclinica

Nov 30, 2017 The Pharma Life Cycle: Plagued with Integration and Data Management Challenges, or Opportunities? LifeScience - Learn how to liberate complex data throughout the pharma life cycle to enable innovation as well as sound and timely decision-making
Speaker: Gary Palgon, Vice President, Healthcare and Life Sciences Solutions, Liaison Technologies

Dec 5, 2017 Deciphering the Complexity of the Acute Leukemia Immunological Microenvironment with 3D Biology™ Technology LifeScience - Learn more about how the combined analysis of SNV, mRNA, and protein expression on the nCounter system enabled a comprehensive characterization of the molecular landscape of leukemia cells
Speakers: Doug Hinerfeld, Ph.D., Principal Product Application Scientist, NanoString Technologies
Sergio Rutella, M.D., Ph.D,, Professor of Cancer Immunotherapy, John van Geest Cancer Research Centre, Nottingham Trent University

Dec 6, 2017 When is Central Imaging Needed in Clinical Trials? LifeScience - This webinar will summarize and highlight the various types of imaging and their role in the clinic and in research, with a perspective on the regulatory aspects that govern its use and practical aspects for pharma, biotech and contract research organizations
Speaker: Souhil Zaim, MD, Head of Global Medical and Science Affairs, Bioclinica

Jan 23, 2018 Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success LifeScience - Thi webinarwill consider methodological improvements associated with recruiting patients into clinical trials, improving patient assessment and retention in trials, the use of cognitive biomarkers to guide decision making about the safety and efficacy of drugs and how to minimize the risk of placebo and practice effects in studies of schizophrenia
Speaker: Dr. Kiri Granger, Director of Neuroscience, Cambridge Cognition

Click here for a list of On Demand Archives

Xtalks Life Science Webinars., 1235 Bay Street, Suite 802 , ON, Toronto, M5R 3K4, Canada
 
Copyright © 2016-2017 Honeycomb Worldwide Inc.